Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 7 Lymphatic Metastasis 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Uterine Neoplasms 1 Urologic Neoplasms 1 Ureteral Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Mixed Tumor, Mesodermal 1 Melanoma 1 Lymphedema 1

Interventions

Radiotherapy 24 Radiotherapy, Intensity-Modulated 8 Radiosurgery 6 Amifostine 5 Low-Level Light Therapy 4 Donepezil 4 Cisplatin 4 Carboplatin 4 Surveys and Questionnaires 3 Radiation 3 Proton Therapy 3 Paclitaxel 3 Neuropsychological Tests 3 Heavy Ion Radiotherapy 3 Etoposide 3 Chemotherapy, Adjuvant 3 Chemoradiotherapy 3 Brachytherapy 3 Bevacizumab 3 Surgical Procedures, Operative 2 Radiation Dose Hypofractionation 2 Patient Reported Outcome Measures 2 Mental Status and Dementia Tests 2 Esophagectomy 2 Androgen Antagonists 2 Adrenal Cortex Hormones 2 sodium propionate 1 sargramostim 1 olaparib 1 endostar protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Radiation Injuries × Lymph Node Excision × Clear all

NCT04889924 2026-05-19

ADARNAT

Hospital Universitari de Bellvitge

Phase NA Recruiting

Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡